YOLUP-H-40
MRP: 1,300
Packaging: 10x10
Pack Type: tablet
Composition:
Olmesartan Medoxomil 40mg + Hydrochlorothiazide 12.5mg
Indication:
Essential Hypertension, Congestive Heart Failure, Proteinuria, High Risk Patients.
Description:
Olmesartan Medoxomil 40mg + Hydrochlorothiazide 12.5mg is a potent combination therapy used to treat hypertension (high blood pressure). Olmesartan, an angiotensin II receptor blocker (ARB), works by relaxing blood vessels, while Hydrochlorothiazide, a thiazide diuretic, helps eliminate excess salt and water through increased urine output. Together, they provide effective and sustained blood pressure control, reducing the risk of cardiovascular complications such as heart attack, stroke, and kidney damage. This once-daily tablet is ideal for patients needing stronger blood pressure management with dual-action therapy.
Tags:
- Strong, dual-action blood pressure control
- Reduces risks of stroke, heart attack, and kidney damage
- Convenient once-daily dosing promotes adherence
- Combats fluid retention and vascular resistance simultaneously
- Suitable for patients needing enhanced hypertension management
Usage Information
Dosage
Take one tablet once daily, with or without food Swallow the tablet whole; do not crush or chew Follow your doctor’s instructions strictly Regularly monitor blood pressure and kidney function
Side Effects
Common: dizziness, headache, increased urination, fatigue Possible: low potassium, dehydration, electrolyte imbalance Rare: angioedema, severe allergic reactions Seek immediate help if you experience swelling of face, lips, or difficulty breathing
Contraindications
Hypersensitivity to Olmesartan, Hydrochlorothiazide, or sulfonamides Severe kidney impairment or anuria Pregnancy and breastfeeding (consult physician) Severe liver disease Avoid use with aliskiren in patients with diabetes or renal impairment